Each year, the American Urological Association (AUA) hosts the largest gathering of urologists in the world. AUA 2023 will be held April 28 – May 1 in Chicago, IL, with a virtual attendance option. The annual meeting provides international urologic experts with access to the latest evidence-based science in urology, including plenary sessions, instructional courses, updates on the new 2023 clinical guidelines, and more.
Leaders from the Division of Urology and the Center for Surgery and Public Health at Brigham and Women’s Hospital will have a strong presence at this event, giving several groundbreaking presentations throughout the weekend.
Brigham Presenters
Edoardo Beatrici, MD
May 1, 9:30 a.m. – 11:30 a.m.
Stage and Grade Migration of Prostate Cancer During the COVID-19 Pandemic
Principal Investigator: Quoc-Dien Trinh, MD, MBA
Logan Briggs, MD
May 1, 7:00 a.m. – 9:00 a.m.
Predicting Peak Productivity in Urologic Practice via Work-related Values
Principal Investigator: Quoc-Dien Trinh, MD, MBA
Vincent D’Andrea, MD
April 28, 1:00 p.m. – 3:00 p.m.
Synergistic Antitumor Activity of PI3K Inhibition and Immune Checkpoint Blockade in Bladder Cancer
Principal Investigator: Juan Garisto, MD
April 29, 9:30 a.m. – 11:30 a.m.
Anticoagulation Prophylaxis Patterns following Retroperitoneal Lymph Node Dissection: A Ten-Year Retrospective Analysis
Principal Investigator: Timothy N. Clinton, MD
April 30, 7:00 a.m. – 9:00 a.m. (Podium Presentation)
Phototherapy With a Cancer-specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer
Principal Investigator: Juan Garisto, MD
Dejan K. Filipas, MD
April 30, 1:00 p.m. – 3:00 p.m.
The Effect of Indeterminate Pathologic Margins on Survival After Surgery for Renal Cell Carcinoma
Principal Investigator: Quoc-Dien Trinh, MD, MBA
Nicola Frego, MD
May 1, 7:00 a.m. – 9:00 a.m. (Podium Presentation)
Effect of Shared Decision Making on Racial and Ethnic Disparity in Prostate Cancer Screening: Results From a National Behavioral Survey
Principal Investigator: Alexander Putnam Cole, MD
May 1, 9:30 a.m. – 11:30 a.m.
Effect of Type of Definitive Treatment on Race-based Differences in Prostate Cancer-specific Survival
Principal Investigator: Alexander Putnam Cole, MD
Catherine Gu, MD
April 28, 9:30 a.m. – 11:30 a.m.
Disparities in Refusal of Systematic Therapy in Metastatic Prostate Cancer
Principal Investigator: Quoc-Dien Trinh, MD, MBA
April 28, 1:00 p.m. – 3:00 p.m.
Comparing Costs and Benefits of Open vs Robotic Simple Prostatectomy
Tracy X. Han, MD
May 1, 7:00 a.m. – 9:00 a.m.
Decreased Utilization of Low-value Health Care Services During the COVID-19 Pandemic
Principal Investigator: Quoc-Dien Trinh, MD, MBA
Mara Koelker, MD
May 1, 1:00 p.m. – 3:00 p.m.
Racial Differences in Patient-reported Outcomes Among Men Treated With Radical Prostatectomy for Prostate Cancer
Principal Investigator: Quoc-Dien Trinh, MD, MBA
Muhieddine Labban, MD
April 29, 1:00 p.m. – 3:00 p.m. (Podium Presentation)
Race-based Trends in the Proportion of Metastatic Prostate Cancer at Diagnosis Between 2005 and 2020: Findings From the National Cancer Database
Principal Investigator: Alexander Putnam Cole, MD
May 1, 1:00 p.m. – 3:00 p.m.
Pharmacovigilance Analysis of Melanoma Adverse Events in Men Treated With Sildenafil for Erectile Dysfunction
Principal Investigator: Quoc-Dien Trinh, MD, MBA
May 1, 1:00 p.m. – 3:00 p.m.
Trends and Safety Profile of Same-day Discharge for Robot-assisted Laparoscopic Prostatectomy: A Retrospective Analysis of Two Tertiary Centers in the Northeastern United States
Principal Investigator: Quoc-Dien Trinh, MD, MBA
Ikenna Madueke, MD
Marco Paciotti, MD
April 28, 9:30 a.m. – 11:30 a.m.
Predicting the Impact of Improving Quality of Care at Minority-serving Hospitals on National Racial/Ethnic Disparities: Effects on the Definitive Treatment of Breast, Colon, Lung, and Prostate Cancer
Principal Investigator: Quoc-Dien Trinh, MD, MBA
Benjamin V. Stone, MD
April 28, 9:30 a.m. – 11:30 a.m.
The Effect of Limited English Proficiency on PSA Screening Rates in American Men
Principal Investigator: Quoc-Dien Trinh, MD, MBA
April 29, 1:00 p.m. – 3:00 p.m.
The Risk of Catastrophic Healthcare Expenditures Among Prostate and Bladder Cancer Survivors in the United States
Principal Investigator: Quoc-Dien Trinh, MD, MBA
April 29, 1:00 p.m. – 3:00 p.m.
Predictors of Financial Toxicity Among United States Prostate Cancer Survivors: Results From a National Survey
Principal Investigator: Alexander Putnam Cole, MD
April 29, 3:30 p.m. – 5:30 p.m.
Trends in SBRT for Inoperable Renal Cell Carcinoma
Principal Investigator: Soumyajit Roy, MD
Zhiyu (Jason) Qian, MD
April 28, 9:30 a.m. – 11:30 a.m.
Trends in Prostate Specific Antigen Screening Among Younger Men Over the Past Decade – Closing of Racial Gap
Principal Investigator: Quoc-Dien Trinh, MD, MBA
May 1, 9:30 a.m. – 11:30 a.m.
Changes in Prostate Specific Antigen Screening Following the 2018 United States Preventive Services Task Force Guidelines and Through the COVID-19 Pandemic
Principal Investigator: Quoc-Dien Trinh, MD, MBA
Affan Zafar, MD
April 30, 9:30 a.m. – 11:30 a.m.
Long Term Renal Outcmes in Trimodality Therapy for Bladder Cancer
April 30, 9:30 a.m. – 11:30 a.m.
Development and Outcomes of Upper Tract Urothelial Carcinoma Following Trimodality Therapy for Muscle Invasive Bladder Cancer
Presenting on behalf of Jillian Egan, MD